نتائج البحث

Efficacy of everolimus‐based therapy in advanced triple‐positive breast cancer: Experience from three cancer centers in China.

• Authors : Tan, Yujing¹ (AUTHOR); Jiang, Hanfang² (AUTHOR); Ma, Fei¹ (AUTHOR)

• Source: Thoracic Cancer. Dec2023, Vol. 14 Issue 34, p3397-3405. 9p.

تفاصيل العنوان

Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China.

• Authors : Luo, Cong^1,2 (AUTHOR); Zhang, Yu-Shi³ (AUTHOR); Zhang, Ming-Xin⁴ (AUTHOR)

• Source: Orphanet Journal of Rare Diseases. 7/3/2021, Vol. 16 Issue 1, p1-8. 8p.

تفاصيل العنوان

Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy.

• Authors : Ni J; Department of Urology, Xi Jing Hospital, the Fourth Military Medical University, Shaanxi, Xian, 710032, China.; Yan F

Subjects: Angiomyolipoma/Angiomyolipoma/Angiomyolipoma/*genetics ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Everolimus/Everolimus/Everolimus/*administration & dosage

• Source: Scientific reports [Sci Rep] 2019 Oct 04; Vol. 9 (1), pp. 14337. Date of Electronic Publication: 2019 Oct 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.

• Authors : Wei Wu¹; Heran Deng¹; Nanyan Rao¹

• Source: Trials. 10/25/2017, Vol. 18, p1-6. 6p. 2 Charts.

تفاصيل العنوان

Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.

• Authors : Wang Y; Department of Urology, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200433, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 20032, People's Republic of China.

Subjects: Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/pathology ; Kidney Neoplasms*/Kidney Neoplasms*/Kidney Neoplasms*/pathology; Humans

• Source: World journal of surgical oncology [World J Surg Oncol] 2023 Mar 16; Vol. 21 (1), pp. 98. Date of Electronic Publication: 2023 Mar 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Market News.

• Source: Inpharma Weekly. 1/20/2007, Issue 1571, p23-23. 1/9p.

تفاصيل العنوان